We only have this paper's title and publication details.
Read it at the sourceRetrospective study finds exenatide reduces inflammatory markers in type 2 diabetes patients, indicating potential health benefits.
No takes yet. Share an insight, caveat, or question.
Araç et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: